Duraflex Coronary Stent System
Commercial- Indications
- Cardiovascular disease
Company intelligence / Profile preview
Avantec Vascular develops innovative medical devices for the treatment of vascular diseases including coronary artery disease, peripheral vascular disease, and neurovascular disorders. Its commercialized products include the Duraflex™ Coronary Stent System and Apollo™ Coronary Dilatation Catheter. The company has expanded its portfolio to include drug-eluting stents, retrieval systems, neurovascular/peripheral coils, atherectomy devices, and more. In recent years it initiated clinical studies for new vascular devices internationally.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avantec Vascular.